Skip to content
Search

Latest Stories

PDA pledges 'full support' to Rowlands pharmacists

The Pharmacists’ Defence Association (PDA) has pledged full support to its members at Rowlands pharmacies with appropriate help to protect their legal and contractual rights.

This follows Rowlands’ announcement on Monday (October 5) to cut pharmacy opening hours by an average of ten hours per week early in 2021. Pharmacists at Rowlands see the latest move of the company as potential job cuts.


The PDA also assured them of working "appropriately with the company to find agreed solutions with our members whenever possible.”

“This is the latest major closure announcement from a pharmacy multiple in the community sector following significant cuts to government funding for community pharmacy over recent years and sadly it may not be the last,” PDA noted.

The association added: “Our immediate concerns are about the livelihoods and wellbeing of our members who may find themselves in one of the affected Rowlands pharmacies.

“Many employees will have statutory protections regarding their contracts, job security and/or redundancy entitlement; however, we urge any affected PDA members to contact us so that we can provide advice on their individual position. The PDA team includes experts in employment law so we can help with many aspects of such a change.”

PDA has urged the employer to invest in adequate staffing and other resources for the long-term benefit of all.

Mark Pitt, director of defence at PDA, said: “Our members at Rowlands will be understandably concerned about this announcement.  We are already hearing from those who expect to be directly affected and others who have worries about their pharmacy.  Once more details are known we will be able to help individuals with any specific concerns.

“Pharmacists can be reassured that the PDA will help members protect their employment rights and ensure they are treated fairly.  Members should contact us for advice if they are impacted by these proposed changes.”

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less